Immunovaccine Inc.
Profile
Mailing Address: 1344 Summer Street, Suite 412
Halifax, Nova Scotia
B3H 0A8
Head Office Address: 1344 Summer Street, Suite 412
Halifax, Nova Scotia
B3H 0A8
Contact Name: Pierre Labbé, Chief Financial Officer Principal Regulator: Nova Scotia
Business e-mail address: plabbe@imvaccine.com Short Form Prospectus Issuer: Yes
Telephone Number: 902 492-1819 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Nova Scotia, Newfoundland
Fax Number: 902 492-0888 Stock Exchange: TSX
Date of Formation: May 18 2007 Stock Symbol: IMV
Jurisdiction Where Formed: Canada Auditor: PriceWaterhouseCoopers LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 45254B Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $5,000,001 to $25,000,000


View This Company's Documents